Bismuth sulfide(Bi_(2)S_(3))has attracted particular interest as a potential anode material for sodium-ion batteries(SIBs).However,the low electrical conductivity and dramatic volumetric change greatly restrict its pr...Bismuth sulfide(Bi_(2)S_(3))has attracted particular interest as a potential anode material for sodium-ion batteries(SIBs).However,the low electrical conductivity and dramatic volumetric change greatly restrict its practical applications.In view of the apparent structural and compositional advantages of metal-organic frameworks(MOFs)derived carbon-based composite,herein,as a proof of concept,Bi_(2)S_(3) spheres coated with the MOF-derived Co_(9)S_(8) and N-doped carbon composite layer(Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres)have been rational designed and synthesized.As expected,the core-shell Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres exhibit remarkable electrochemical performance in terms of high reversible capacity(597 m Ah g^(-1) after 100 cycles at 0.1 A g^(-1)),good rate capability(341 m Ah g^(-1) at 8 A g^(-1))and long-term cycling stability(458 m Ah g^(-1) after 1000 cycles at 1 A g^(-1))when investigated as anode materials for SIBs.Electrochemical analyses further reveal the favorable reaction kinetics in the Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres.In addition,the possible sodium storage mechanism has been studied by ex-situ X-ray diffraction technique.More importantly,a sodium-ion full cell based on Na_(3) V_(2)(PO_(4))_(3)/r GO as cathode and Bi_(2)S_(3)@Co_(9)S_(8)/NC as anode is also fabricated,suggesting their potential for practical applications.It is anticipated that the present work could be extended to construct other advanced electrode materials using MOFs-derived carbon-based composites as surface coating materials for various energy storagerelated applications.展开更多
The number of people with Alzheimer’s disease(AD)is increasing annually,with the nidus mainly concentrated in the cortex and hippocampus.Despite of numerous efforts,effective treatment of AD is still facing great cha...The number of people with Alzheimer’s disease(AD)is increasing annually,with the nidus mainly concentrated in the cortex and hippocampus.Despite of numerous efforts,effective treatment of AD is still facing great challenges due to the blood brain barrier(BBB)and limited drug distribution in the AD nidus sites.Thus,in this study,using vinpocetine(VIN)as a model drug,the objective is to explore the feasibility of tackling the above bottleneck via intranasal drug delivery in combination with a brain guider,borneol(BOR),using nanoemulsion(NE)as the carrier.First of all,the NE were prepared and characterized.In vivo behavior of the NE after intranasal administration was investigated.Influence of BOR dose,BOR administration route on drug brain targeting behavior was evaluated,and the influence of BOR addition on drug brain subregion distribution was probed.It was demonstrated that all the NE had comparable size and similar retention behavior after intranasal delivery.Compared to intravenous injection,improved brain targeting effect was observed by intranasal route,and drug targeting index(DTI)of the VIN–NE group was 154.1%,with the nose-to-brain direct transport percentage(DTP)35.1%.Especially,remarkably enhanced brain distribution was achieved after BOR addition in the NE,with the extent depending on BOR dose.VIN brain concentration was the highest in the VIN-1-BOR-NE group at BOR dose of 1 mg/kg,with the DTI reaching 596.1%and the DTP increased to 83.1%.BOR could exert better nose to brain delivery when administrated together with the drug via intranasal route.Notably,BOR can remarkably enhance drug distribution in both hippocampus and cortex,the nidus areas of AD.In conclusion,in combination with intranasal delivery and the intrinsic brain guiding effect of BOR,drug distribution not only in the brain but also in the cortex and hippocampus can be enhanced significantly,providing the perquisite for improved therapeutic efficacy of AD.展开更多
Virus-capsid mimicking mucus-permeable nanoparticles are promising oral insulin carriers which surmount intestinal mucus barrier.However,the impact of different viruscapsid mimicking structure remains unexplored.In th...Virus-capsid mimicking mucus-permeable nanoparticles are promising oral insulin carriers which surmount intestinal mucus barrier.However,the impact of different viruscapsid mimicking structure remains unexplored.In this study,utilizing biotin grafted chitosan as the main skeleton,virus-mimicking nanoparticles endowed with biologicshell(streptavidin coverage)and polymeric-shell(hyaluronic acid/alginate coating)were designed with insulin as a model drug by self-assembly processes.It was demonstrated that biologic-shell mimicking nanoparticles exhibited a higher intestinal trans-mucus(>80%,10 min)and transmucosal penetration efficiency(1.6–2.2-fold improvement)than polymeric-shell counterparts.Uptake mechanism studies revealed caveolae-mediated endocytosis was responsible for the absorption of biologic-shell mimicking nanoparticles whereas polymeric-shell mimicking nanoparticles were characterized by clathrin-mediated pathway with anticipated lysosomal insulin digestion.Further,in vivo hypoglycemic study indicated that the improved effect of regulating blood sugar levels was virus-capsid structure dependent out of which biologic-shell mimicking nanoparticles presented the best performance(5.1%).Although the findings of this study are encouraging,much more work is required to meet the standards of clinical translation.Taken together,we highlight the external structural dependence of virus-capsid mimicking nanoparticles on the mucopenetrating and uptake mechanism of enterocytes that in turn affecting their in vivo absorption,which should be pondered when engineering virus-mimicking nanoparticles for oral insulin delivery.展开更多
基金the financial support from the Central Government Research Programs to Guide the Local Scientific and Technological Development(Grant no.2018L3001)the National Natural Science Foundation of China(Grant nos.51872048 and U1732155)the Natural Science Foundation of Fujian Province,China(Grant no.2018J01677)。
文摘Bismuth sulfide(Bi_(2)S_(3))has attracted particular interest as a potential anode material for sodium-ion batteries(SIBs).However,the low electrical conductivity and dramatic volumetric change greatly restrict its practical applications.In view of the apparent structural and compositional advantages of metal-organic frameworks(MOFs)derived carbon-based composite,herein,as a proof of concept,Bi_(2)S_(3) spheres coated with the MOF-derived Co_(9)S_(8) and N-doped carbon composite layer(Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres)have been rational designed and synthesized.As expected,the core-shell Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres exhibit remarkable electrochemical performance in terms of high reversible capacity(597 m Ah g^(-1) after 100 cycles at 0.1 A g^(-1)),good rate capability(341 m Ah g^(-1) at 8 A g^(-1))and long-term cycling stability(458 m Ah g^(-1) after 1000 cycles at 1 A g^(-1))when investigated as anode materials for SIBs.Electrochemical analyses further reveal the favorable reaction kinetics in the Bi_(2)S_(3)@Co_(9)S_(8)/NC composite spheres.In addition,the possible sodium storage mechanism has been studied by ex-situ X-ray diffraction technique.More importantly,a sodium-ion full cell based on Na_(3) V_(2)(PO_(4))_(3)/r GO as cathode and Bi_(2)S_(3)@Co_(9)S_(8)/NC as anode is also fabricated,suggesting their potential for practical applications.It is anticipated that the present work could be extended to construct other advanced electrode materials using MOFs-derived carbon-based composites as surface coating materials for various energy storagerelated applications.
基金supported by the Distinguished Professor Project of Liaoning Province.
文摘The number of people with Alzheimer’s disease(AD)is increasing annually,with the nidus mainly concentrated in the cortex and hippocampus.Despite of numerous efforts,effective treatment of AD is still facing great challenges due to the blood brain barrier(BBB)and limited drug distribution in the AD nidus sites.Thus,in this study,using vinpocetine(VIN)as a model drug,the objective is to explore the feasibility of tackling the above bottleneck via intranasal drug delivery in combination with a brain guider,borneol(BOR),using nanoemulsion(NE)as the carrier.First of all,the NE were prepared and characterized.In vivo behavior of the NE after intranasal administration was investigated.Influence of BOR dose,BOR administration route on drug brain targeting behavior was evaluated,and the influence of BOR addition on drug brain subregion distribution was probed.It was demonstrated that all the NE had comparable size and similar retention behavior after intranasal delivery.Compared to intravenous injection,improved brain targeting effect was observed by intranasal route,and drug targeting index(DTI)of the VIN–NE group was 154.1%,with the nose-to-brain direct transport percentage(DTP)35.1%.Especially,remarkably enhanced brain distribution was achieved after BOR addition in the NE,with the extent depending on BOR dose.VIN brain concentration was the highest in the VIN-1-BOR-NE group at BOR dose of 1 mg/kg,with the DTI reaching 596.1%and the DTP increased to 83.1%.BOR could exert better nose to brain delivery when administrated together with the drug via intranasal route.Notably,BOR can remarkably enhance drug distribution in both hippocampus and cortex,the nidus areas of AD.In conclusion,in combination with intranasal delivery and the intrinsic brain guiding effect of BOR,drug distribution not only in the brain but also in the cortex and hippocampus can be enhanced significantly,providing the perquisite for improved therapeutic efficacy of AD.
基金financial support from National Natural Science Foundation of China(grant no.31870987)
文摘Virus-capsid mimicking mucus-permeable nanoparticles are promising oral insulin carriers which surmount intestinal mucus barrier.However,the impact of different viruscapsid mimicking structure remains unexplored.In this study,utilizing biotin grafted chitosan as the main skeleton,virus-mimicking nanoparticles endowed with biologicshell(streptavidin coverage)and polymeric-shell(hyaluronic acid/alginate coating)were designed with insulin as a model drug by self-assembly processes.It was demonstrated that biologic-shell mimicking nanoparticles exhibited a higher intestinal trans-mucus(>80%,10 min)and transmucosal penetration efficiency(1.6–2.2-fold improvement)than polymeric-shell counterparts.Uptake mechanism studies revealed caveolae-mediated endocytosis was responsible for the absorption of biologic-shell mimicking nanoparticles whereas polymeric-shell mimicking nanoparticles were characterized by clathrin-mediated pathway with anticipated lysosomal insulin digestion.Further,in vivo hypoglycemic study indicated that the improved effect of regulating blood sugar levels was virus-capsid structure dependent out of which biologic-shell mimicking nanoparticles presented the best performance(5.1%).Although the findings of this study are encouraging,much more work is required to meet the standards of clinical translation.Taken together,we highlight the external structural dependence of virus-capsid mimicking nanoparticles on the mucopenetrating and uptake mechanism of enterocytes that in turn affecting their in vivo absorption,which should be pondered when engineering virus-mimicking nanoparticles for oral insulin delivery.
